Product Name: | (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-ol |
CAS Registry Number: | 72-33-3 |
EINECS: | 200-777-8 |
Synonyms: |
Compound 33355; EE(sub3)ME; Menophase; Mestranolum; 72-33-3;Devocin;(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-ol; Ovastol; Ethynylestradiol 3-methyl ether; Norquen; |
Molecular Structure: | |
Molecular Formula: | C21H26O2 |
Molecular Weight: | 310.42994 |
Density: | 0.905g/cm3 |
Boiling Point: | 464.1°C at 760 mmHg |
Melting Point: | 150-154 ºC |
Flash Point: | 224.1°C |
Refractive index: | 1.49 |
Risk Codes: | R36/37/38;R40;R48 |
Safety Statements: | Confirmed carcinogen with experimental neoplastigenic, tumorigenic, and teratogenic data. Moderately toxic by subcutaneous route. Human reproductive effects by ingestion: changes in ovaries and fallopian tubes, fertility effects. Experimental reproductive effects. Mutation data reported. An FDA proprietary drug. A steroid used in oral contraceptives. When heated to decomposition it emits acrid smoke and irritating fumes. |
Hazard Symbols: | Xn: Harmful; |